Dataset from A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Paliperidone Palmitate 3-Month Formulation in Subjects With Schizophrenia
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008736
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the pharmacokinetics, safety, and tolerability of a
paliperidone palmitate 3-month formulation in patients with schizophrenia.
创建时间：
2025-01-29
